ClinConnect ClinConnect Logo
Search / Trial NCT03283852

Identifying New Genetic Causes to Development Disorders

Launched by FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD · Sep 13, 2017

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking to understand the genetic causes behind certain growth and development disorders, such as problems with puberty and sex development. Researchers will use a technique called exome analysis, which helps identify new genetic mutations that could be responsible for these issues. By participating, the trial aims to uncover how common these mutations are and whether they relate to other health problems.

If you or someone you know has conditions like congenital growth hormone deficiency, puberty disorders, or disorders of sex development, you might be eligible to join the study. Family members of patients with these conditions can also participate. The trial is currently recruiting participants of all ages and genders. Those who take part will help researchers learn more about these disorders, which could lead to better understanding and treatment options in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • congenital growth hormone deficiency
  • puberty disorder
  • gonadal dysgenesis or anorchia
  • primary ovarian failure
  • disorder of sex development
  • subjects related to a patient with one of the above criteria
  • Exclusion Criteria:
  • environmental or auto-immune cause

About Fondation Ophtalmologique Adolphe De Rothschild

The Fondation Ophtalmologique Adolphe de Rothschild is a leading French institution dedicated to advancing ophthalmic research and patient care. Renowned for its commitment to innovation in eye health, the foundation conducts cutting-edge clinical trials aimed at improving treatments for various ocular conditions. With a multidisciplinary team of experts, the foundation collaborates with academic and industry partners to enhance understanding of eye diseases and develop novel therapeutic solutions, ultimately striving to improve patient outcomes and quality of life in ophthalmology.

Locations

Paris, , France

Patients applied

0 patients applied

Trial Officials

Raja Brauner, PU-PH

Principal Investigator

Hôpital Fondation A. de Rothschild

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials